Radicava

May 7, 2019August 2, 2019

#AANAM — Radicava May Limit Functional Decline in ALS Patients, Review Study Suggests

News, Radicava

Radicava (edaravone) may prevent functional deterioration in amyotrophic lateral sclerosis (ALS) patients, results from a literature review suggest. Findings from the review, “Safety and Efficacy of Edaravone in Delaying Functional ... Read more

March 29, 2019July 23, 2019

MTPA, Massachusetts General Launching Study on Biomarkers of Radicava Response

News, Radicava

Mitsubishi Tanabe Pharma America (MTPA), in collaboration with the Massachusetts General Hospital (MGH), is conducting a study to identify biomarkers related to amyotrophic lateral sclerosis (ALS), which may be helpful to measure ... Read more

October 9, 2018July 23, 2019

Health Canada Authorizes Radicava for Treatment of ALS

News, Radicava

Canadian authorities have approved the sale of Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). The therapy will be marketed by Mitsubishi Tanabe Pharma Canada (MTP-CA), a unit of Mitsubishi Tanabe ... Read more

May 24, 2018July 23, 2019

Clinigen, Mitsubishi Tanabe Announce Early Access Program in Europe for ALS Therapy Radicava

News, Radicava

Clinigen Group recently partnered with Mitsubishi Tanabe Pharma Corporation to launch an early access program in Europe for Radicava (edaravone), an intravenous treatment for amyotrophic lateral sclerosis (ALS). The therapy ... Read more

January 18, 2018July 23, 2019

Ethical Factors Should Be at Core of Radicava Treatment Discussions, Researchers Argue

News, Radicava

When discussing potential Radicava (edaravone) treatment with amyotrophic lateral sclerosis (ALS) patients, physicians need to take great care in presenting facts in an ethical and scientifically sound manner, warn two ... Read more

December 7, 2017July 23, 2019

Radicava and Its Decisive Phase 3 Trial Among Presentations at ALS/MND Meeting This Weekend

News, Radicava

Additional data on Radicava (edaravone) and the clinical trial that led to its approval to treat amyotrophic lateral sclerosis (ALS) will be presented in oral and poster presentations at the 28th International ... Read more

December 4, 2017July 23, 2019

VA Adds Radicava to its National Formulary for ALS Patients

News, Radicava

The U.S. Department of Veterans Affairs (VA) has added Radicava (edaravone) to its national formulary (VANF), making it possible for veterans with amyotrophic lateral sclerosis (ALS) to access treatment within ... Read more

November 29, 2017July 23, 2019

ALS Association’s Incoming CEO Urges Insurers to Expand Narrow Coverage of Radicava

News, Radicava

WASHINGTON — Visitors to the ALS Association’s Washington, D.C., headquarters can’t help but notice the silver baseball bat sitting in a glass display case at the entrance. An inscription says ... Read more

November 6, 2017July 23, 2019

Option Care, ALS Association Partner to Offer Radicava Home Infusion Services

News, Radicava

Option Care Enterprises, a Chicago-based independent provider of home and alternate treatment site infusion services, has partnered with the ALS Association to offer Radicava (edaravone) treatment from the comfort of their homes. ... Read more

Pin It on Pinterest